Home > Financial Ratios > WANBURY

WANBURY
Core EBITDA Growth

    Back to All Ratios
WANBURY is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for WANBURY
Please provide your vote to see the results

WANBURY Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 203.06-34.5980.29-16.93-1.14

What is the latest Core EBITDA Growth ratio of WANBURY ?

The latest Core EBITDA Growth ratio of WANBURY is 203.06 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024203.06
Mar2023-34.59
Mar202280.29
Mar2021-16.93
Mar2020-1.14

How is Core EBITDA Growth of WANBURY Trending?

Years Core EBITDA Growth % Change
Mar2024 203.06
Positive
Mar2023 -34.59
Negative
Mar2022 80.29
Positive
Mar2021 -16.93
Negative
Mar2020 -1.14 -

Other Financial Ratios of WANBURY


Compare Core EBITDA Growth ratio of peers of WANBURY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WANBURY ₹872.7 Cr 1.5% -8% -7.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹392,567.0 Cr -2% 2% -16.2% Stock Analytics
DIVIS LABORATORIES ₹151,601.0 Cr -5% -6.6% 5.9% Stock Analytics
CIPLA ₹122,284.0 Cr -2.4% -5.4% -8.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,593.0 Cr -0.4% 0.5% 5.2% Stock Analytics
DR REDDYS LABORATORIES ₹104,014.0 Cr -5.8% -4.4% -8.4% Stock Analytics


WANBURY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WANBURY

1.5%

-8%

-7.1%

SENSEX

-0.9%

0.8%

-5.7%


You may also like the below Video Courses